2025
ICD-10-CM
Section

T36-T50 Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances

  • Non-billable
  • 2016–2025

Notes

  • The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.

Includes

  • Adverse effect of correct substance properly administered

  • Poisoning by overdose of substance

  • Poisoning by wrong substance given or taken in error

  • Underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed

Code first

  • For adverse effects, the nature of the adverse effect, such as:

    • Adverse effect NOS (T88.7)

    • Aspirin gastritis (K29.-)

    • Blood disorders (D56-D76)

    • Contact dermatitis (L23-L25)

    • Dermatitis due to substances taken internally (L27.-)

    • Nephropathy (N14.0-N14.2)

Use additional code

  • Code(s) to specify:

    • Manifestations of poisoning

    • Underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)

    • Underdosing of medication regimen (Z91.12-, Z91.13-)

Type 1 excludes

  • Toxic reaction to local anesthesia in pregnancy (O29.3-)

Type 2 excludes

  • Abuse and dependence of psychoactive substances (F10-F19)

  • Abuse of non-dependence-producing substances (F55.-)

  • Immunodeficiency due to drugs (D84.821)

  • Drug reaction and poisoning affecting newborn (P00-P96)

  • Pathological drug intoxication (inebriation) (F10-F19)

Codes

Versions

  1. 2025

    No changes

  2. 2024

    No changes

  3. 2023

    No changes

  4. 2022

    No changes

  5. 2021

    Code changed

    • Type 2 excludes

        • abuse and dependence of psychoactive substances (F10-F19)
        • abuse of non-dependence-producing substances (F55.-)
        • drug reaction and poisoning affecting newborn (P00-P96)
        • pathological drug intoxication (inebriation) (F10-F19)
        • abuse and dependence of psychoactive substances (F10-F19)
        • abuse of non-dependence-producing substances (F55.-)
        • immunodeficiency due to drugs (D84.821)
        • drug reaction and poisoning affecting newborn (P00-P96)
        • pathological drug intoxication (inebriation) (F10-F19)
  6. 2020

    No changes

  7. 2019

    Code changed

    • Code first

        • , for adverse effects, the nature of the adverse effect, such as:
        • adverse effect NOS (T88.7 )
        • aspirin gastritis (K29.-)
        • blood disorders (D56-D76 )
        • contact dermatitis (L23-L25 )
        • dermatitis due to substances taken internally (L27.-)
        • nephropathy (N14.0-N14.2)
        • , for adverse effects, the nature of the adverse effect, such as:
        • adverse effect NOS (T88.7)
        • aspirin gastritis (K29.-)
        • blood disorders (D56-D76)
        • contact dermatitis (L23-L25)
        • dermatitis due to substances taken internally (L27.-)
        • nephropathy (N14.0-N14.2)
  8. 2018

    No changes

  9. 2017

    No changes

  10. 2016

    New code